5 completed, 1 suspended. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 5, Suspended 1 |
Follow Common Wart: new trials by email Literature Review of Common Wart trials Research Report on Common Wart
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart | Phase 2 | Suspended | G&E Herbal Biotechnology Co., LTD | 102 | 2030-09-01 | 2023-09-14 |
| OM202JP Clinical Study of KNP2002 KNP2002, Placebo of KNP2002 - Common Wart | Phase 2 | Completed | KinoPharma Inc. | 159 | 2023-06-12 | 2024-09-27 |
| Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts VDMN-21 Patch Low Dose, VDMN-21 Patch High Dose, Vehicle Patch - Verruca Vulgaris, Warts | Phase 2 | Completed | Veradermics, Inc. | 153 | 2023-02-28 | 2025-05-08 |
| Cantharidin and Occlusion in Verruca Epithelium VP-102 Cantharidin topical film forming solution, VP-102 Cantharidin, topical film forming solution - Common Wart, Warts Hand | Phase 2 | Completed | Verrica Pharmaceuticals Inc. | 56 | 2018-03-27 | 2024-11-27 |
| A Phase2 of A-101 Topical Solution in Subjects With Common Warts A-101 Topical Solution, A-101 Vehicle Solution - Common Wart | Phase 2 | Completed | Aclaris Therapeutics, Inc. | 157 | 2017-08-01 | 2019-05-01 |
| A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts A-101 Topical Solution, A-101 Vehicle Solution - Common Wart | Phase 2 | Completed | Aclaris Therapeutics, Inc. | 159 | 2017-07-13 | 2019-04-09 |
Warts (6) · DNA Virus Infections (1) · Papillomavirus Infections (1) · Skin Diseases (1) · Skin Diseases, Infectious (1) · Skin Diseases, Viral (1) · Tumor Virus Infections (1) · Virus Diseases (1)
Infections (6) · Skin and Connective Tissue Diseases (6) · DNA Virus Infections (5) · Papillomavirus Infections (5) · Skin Diseases (5) · Skin Diseases, Infectious (5) · Skin Diseases, Viral (5) · Tumor Virus Infections (5) · Virus Diseases (5) · Communicable Diseases (1) · Disease Attributes (1) · Genital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Sexually Transmitted Diseases (1)
Aclaris Therapeutics, Inc. (2) · G&E Herbal Biotechnology Co., LTD (1) · KinoPharma Inc. (1) · Veradermics, Inc. (1) · Verrica Pharmaceuticals Inc. (1)
United States (4) · Japan (1)
Adnan Nasir, MD (1) · Hamm-Ming Sheu, MD (1) · Kou-Wha Kuo, Ph.D (1) · Scott Guenthner, MD (1) · Stuart D Shanler, MD (1)